BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus. - Wikidata - wikimedia - TriplyDB

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

http://www.wikidata.org/entity/Q38013996

about

Profile of atacicept and its potential in the treatment of systemic lupus erythematosus B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences TACI expression and signaling in chronic lymphocytic leukemia Protein microarray analysis reveals BAFF-binding autoantibodies in systemic lupus erythematosus.Importance of reverse signaling of the TNF superfamily in immune regulation.Behçet's syndrome pathophysiology and potential therapeutic targets.Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?Update on B-cell targeted therapies for systemic lupus erythematosus.Emerging biological therapies for systemic lupus erythematosus.Signaling mechanisms regulating B-lymphocyte activation and tolerance.Biological and targeted therapies of systemic lupus erythematosus: evidence and the state of the art.Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.Glucocorticoid-induced leucine zipper expression is associated with response to treatment and immunoregulation in systemic lupus erythematosus.

P2860

Q26849719-E5DE1BEC-F54D-4A06-AFC2-D656B2D4C197 Q33822678-0526A9FF-C734-4DD0-98AB-BB4F40C993CC Q35534809-F74865CF-CCF2-4733-A948-D6EC259BC920 Q37384057-A9582364-1EC3-4648-B1EF-938B4FCB78CF Q38096027-0C34EF5C-7C6F-4D61-BBE4-9330D335256F Q38177749-473A4ADD-EC72-493F-819E-9C04866780DE Q38184585-863D99DA-A38B-4C68-9C50-2DF65E30A972 Q38192656-08C776AE-4EFE-4EB0-95A6-62987B6137DB Q38192683-FB72A940-71EA-41BE-85B6-EF4B20569804 Q38334794-20CB1267-A658-4D1B-9200-724F664A2A7F Q38690844-1B801D21-9DE2-4D73-A12B-00137119188B Q38747383-23BB8A0D-EC68-4FE4-AABF-27CE9700CEF0 Q47734736-1DE0A3F1-D9DE-4CA3-A811-BB5AFE359869

P2860

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

http://www.wikidata.org/entity/Q38013996

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

@en

type

label

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

@en

prefLabel

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

@en

P1433

Q38013996-2895AD51-3CC4-41A8-978A-D2971CC1EDC3

P1476

Q38013996-FA5F86DF-ECAD-42EC-8C22-BCD527BE1D01

P2093

Q38013996-2E224A28-5056-4DBD-AD8D-C66832B4AB4D

Q38013996-A0134ED6-0CF3-4BFC-8370-91AF35B849F5

P2860

Q38013996-02F56737-A667-4A1B-97AE-B113E03FD9BC

Q38013996-0FE000A0-2774-406A-8C16-2E08709975D5

Q38013996-11DE09F7-5CC2-4DBB-83A5-77B5D33BFFE2

Q38013996-144990CF-D0C3-414D-A202-434744939A8C

Q38013996-253D3D9B-08D4-4A83-9991-06E50BAF1EBD

Q38013996-2D7B3D62-F09D-4BC9-BFE2-8A38646FBFF5

Q38013996-2E6BE5C1-D3E4-4100-B189-6DCCC4E69425

Q38013996-3FFBBE32-E7F5-450D-9881-06199AB0D127

Q38013996-44318AAE-CF76-41DD-8F86-4C0BC314B41C

Q38013996-4C691A61-CB74-423C-A144-505E54180A26

P304

Q38013996-3B619D4A-7D6D-44C3-B9D0-3C712C478A6E

P31

Q38013996-EBD18A63-7622-493F-BF17-8814A92599FD

P356

Q38013996-B589DFC4-FAF3-4B95-8C0F-1C36D9B1393D

P407

Q38013996-A8054DF8-1FDF-4CFC-A929-4347079CE61B

P433

Q38013996-7753A447-78DC-4B51-9E22-63D42D5683B8

P478

Q38013996-3C63478A-2366-48AF-AAE1-9F8D3A2E44AA

P50

Q38013996-8D59B055-62C5-49F4-A31D-47E065A010F8

P577

Q38013996-2E5EFAA2-9024-4553-BFD5-D396FCEA2737

P5875

Q38013996-27E1F016-B6F0-429D-A990-556EB9FB1E92

P698

Q38013996-7FCF1760-9A16-4DA1-8646-7417494F22FF

P356

P1433

P1476

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus

@en

P2093

Fabienne Mackay

http://www.w3.org/2001/XMLSchema#string

Ian R Mackay

http://www.w3.org/2001/XMLSchema#string

P2860

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2

Ligand-receptor binding revealed by the TNF family member TALL-1

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase

Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

BCMA is essential for the survival of long-lived bone marrow plasma cells

P304

595-602

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IUB.1046

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P50

Kirsten A Fairfax

P577

2012-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225069190

http://www.w3.org/2001/XMLSchema#string

P698

22641424

http://www.w3.org/2001/XMLSchema#string